HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lancaster in U.S.

This article was originally published in The Rose Sheet

Executive Summary

Lancaster Group Worldwide Travel Retail & Export is establishing its business in Miami to increase its presence in the Americas and "further develop" the rapidly growing region, Coty's prestige fragrance division announces July 14. The move, in addition to the launch of Glow by J.Lo and acquisition of Kenneth Cole and Marc Jacobs fragrance licenses, is intended to help the company "realize the potential" of the U.S. market, firm adds. Lancaster has stated growth of its U.S. business is a major initiative (1"The Rose Sheet" Oct. 28, 2002, p. 3). Company's retail and export divisions recently were combined to "better coordinate" marketing efforts and ensure high standards to customers...

You may also be interested in...



Lancaster U.S. Expansion Plan Glowing With Addition Of Lopez

Coty's prestige division, Lancaster, is using American licenses such as its agreement with actress/singer Jennifer Lopez to grow its U.S. fragrance business, Senior VP, Cosmetics and American Licenses Catherine Walsh said

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel